ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

3 Overrated Stocks with Warning Signs

INTC Cover Image

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro developments. As such, investors are taking notice and bidding up shares.

But not every company with momentum is a long-term winner, and plenty of investors have lost money betting on short-term fads. On that note, here are three stocks that are likely overheated and some you should look into instead.

Intel (INTC)

One-Month Return: +30.1%

Inventor of the x86 processor that powered decades of technological innovation in PCs, data centers, and numerous other markets, Intel (NASDAQ: INTC) is a leading manufacturer of computer processors and graphics chips.

Why Is INTC Risky?

  1. Sales tumbled by 6.4% annually over the last five years, showing market trends are working against its favor during this cycle
  2. Performance over the past five years shows each sale was less profitable as its earnings per share dropped by 40.7% annually, worse than its revenue
  3. Free cash flow margin dropped by 35.3 percentage points over the last five years, implying the company became more capital intensive as competition picked up

At $48.53 per share, Intel trades at 114.9x forward P/E. Dive into our free research report to see why there are better opportunities than INTC.

Adtalem (ATGE)

One-Month Return: +17%

Formerly known as DeVry Education Group, Adtalem Global Education (NYSE: ATGE) is a global provider of workforce solutions and educational services.

Why Do We Pass on ATGE?

  1. Annual revenue growth of 12.5% over the last five years was below our standards for the consumer discretionary sector
  2. Capital intensity will likely ramp up in the next year as its free cash flow margin is expected to contract by 1.2 percentage points
  3. Underwhelming 10.2% return on capital reflects management’s difficulties in finding profitable growth opportunities

Adtalem is trading at $117.42 per share, or 2.2x forward price-to-sales. To fully understand why you should be careful with ATGE, check out our full research report (it’s free).

Mercury Systems (MRCY)

One-Month Return: +43.4%

Founded in 1981, Mercury Systems (NASDAQ: MRCY) specializes in providing processing subsystems and components for primarily defense applications.

Why Should You Dump MRCY?

  1. Organic sales performance over the past two years indicates the company may need to make strategic adjustments or rely on M&A to catalyze faster growth
  2. Day-to-day expenses have swelled relative to revenue over the last five years as its operating margin fell by 7.6 percentage points
  3. Earnings per share fell by 18.3% annually over the last five years while its revenue grew, partly because it diluted shareholders

Mercury Systems’s stock price of $102.94 implies a valuation ratio of 99.8x forward P/E. Read our free research report to see why you should think twice about including MRCY in your portfolio.

High-Quality Stocks for All Market Conditions

Check out the high-quality names we’ve flagged in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  218.94
+2.12 (0.98%)
AAPL  260.29
-2.23 (-0.85%)
AMD  199.45
-2.62 (-1.30%)
BAC  49.81
-0.49 (-0.97%)
GOOG  300.91
-2.54 (-0.84%)
META  660.57
-7.16 (-1.07%)
MSFT  410.68
+5.48 (1.35%)
NVDA  183.34
+0.30 (0.16%)
ORCL  154.79
+2.42 (1.59%)
TSLA  405.55
-0.39 (-0.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.